232 related articles for article (PubMed ID: 9293074)
21. In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility.
Silva JO; Martins Reis AC; Quesada-Gómez C; Pinheiro AQ; Freire RS; Oriá RB; de Carvalho CB
Anaerobe; 2014 Aug; 28():24-8. PubMed ID: 24799339
[TBL] [Abstract][Full Text] [Related]
22. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
24. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Betriu C; Culebras E; Gómez M; López F; Rodríguez-Avial I; Picazo JJ
Antimicrob Agents Chemother; 2008 Jul; 52(7):2686-90. PubMed ID: 18474575
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
26. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
Goldstein EJ; Citron DM
J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
Karlowsky JA; Walkty AJ; Adam HJ; Baxter MR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2012 Mar; 56(3):1247-52. PubMed ID: 22203594
[TBL] [Abstract][Full Text] [Related]
28. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
García-Rodríguez JE; García-Sánchez JE
Rev Infect Dis; 1990; 12 Suppl 2():S142-51. PubMed ID: 2305180
[TBL] [Abstract][Full Text] [Related]
29. Survey of antimicrobial susceptibility patterns of the bacteria of the Bacteroides fragilis group isolated from the intestinal tract of children.
Nakano V; Avila-Campos MJ
Mem Inst Oswaldo Cruz; 2004 May; 99(3):319-24. PubMed ID: 15273807
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota.
Ulger Toprak N; Celik C; Cakici O; Soyletir G
Anaerobe; 2004 Oct; 10(5):255-9. PubMed ID: 16701525
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
Reig M; Campello MG; Baquero F
J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
[TBL] [Abstract][Full Text] [Related]
33. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
[TBL] [Abstract][Full Text] [Related]
34. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Bandoh K; Ueno K; Watanabe K; Kato N
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
[TBL] [Abstract][Full Text] [Related]
36. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.
Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP
Antimicrob Agents Chemother; 1985 Nov; 28(5):675-7. PubMed ID: 4091530
[TBL] [Abstract][Full Text] [Related]
37. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
[TBL] [Abstract][Full Text] [Related]
38. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
[TBL] [Abstract][Full Text] [Related]
40. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
Brook I; Coolbaugh JC; Walker RI; Weiss E
Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
